Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Heterogeneous Role of Caspase-8 in Fenretinide-Induced Apoptosis in Epithelial Ovarian Carcinoma Cell Lines

Kimberly R. Kalli, Kathryn E. Devine, Myles C. Cabot, Christina R. Arnt, Michael P. Heldebrant, Phyllis A. Svingen, Charles Erlichman, Lynn C. Hartmann, Cheryl A. Conover and Scott H. Kaufmann
Molecular Pharmacology December 2003, 64 (6) 1434-1443; DOI: https://doi.org/10.1124/mol.64.6.1434
Kimberly R. Kalli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn E. Devine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myles C. Cabot
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina R. Arnt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael P. Heldebrant
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phyllis A. Svingen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Erlichman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynn C. Hartmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl A. Conover
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott H. Kaufmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 64 no. 6 1434-1443
DOI 
https://doi.org/10.1124/mol.64.6.1434
PubMed 
14645674

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received April 25, 2003
  • Accepted September 3, 2003
  • Published online November 26, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kimberly R. Kalli,
  2. Kathryn E. Devine,
  3. Myles C. Cabot,
  4. Christina R. Arnt,
  5. Michael P. Heldebrant,
  6. Phyllis A. Svingen,
  7. Charles Erlichman,
  8. Lynn C. Hartmann,
  9. Cheryl A. Conover and
  10. Scott H. Kaufmann
  1. Women's Cancer Program (K.R.K., C.E., L.C.H., C.A.C., S.H.K.), Mayo Clinic Cancer Center; Divisions of Endocrine Research (K.R.K., K.E.D., C.A.C.), Oncology Research (P.A.S., S.H.K.), and Medical Oncology (L.C.H., C.E.), Mayo Clinic; and Department of Molecular Pharmacology (C.R.A., M.P.H., S.H.K.), Mayo Graduate School, Rochester, Minnesota; and John Wayne Cancer Institute at St. John's Health Center, Santa Monica, California (M.C.C.)
  1. Address correspondence to:
    Dr. Kimberly R. Kalli, Endocrine Research Unit, Joseph 5-194, Mayo Clinic and Foundation, 200 First Street S.W., Rochester, MN 55905. E-mail: kalli.kimberly{at}mayo.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2003 to March 2023

AbstractFullPdf
Nov 20039108
Dec 20033610565
Jan 2004347642
Feb 2004155838
Mar 2004164316
Apr 200410257
May 2004173721
Jun 2004274516
Jul 2004323512
Aug 200416639
Sep 200437546
Oct 200422222
Nov 200411203
Dec 200419224
Jan 200536426
Feb 200518434
Mar 2005153310
Apr 20054138
May 20057198
Jun 200510179
Jul 2005132717
Aug 200514287
Sep 20054243
Oct 200510349
Nov 2005112211
Dec 200512234
Jan 20067216
Feb 2006133110
Mar 200692511
Apr 200672414
May 20064245
Jun 20065142
Jul 200612156
Aug 2006575
Sep 20066116
Oct 20062237
Nov 20062258
Dec 20064126
Jan 20074186
Feb 200711710
Mar 2007351
Apr 20072164
May 2007665
Jun 20074166
Jul 20073209
Aug 200731911
Sep 2007475
Oct 20073185
Nov 2007494
Dec 2007171
Jan 20082148
Feb 2008789
Mar 20081141
Apr 20081585
May 2008301310
Jun 200814113
Jul 200825102
Aug 200826214
Sep 200813101
Oct 20081773
Nov 200827137
Dec 2008884
Jan 2009111412
Feb 200913178
Mar 200925125
Apr 2009771
May 2009462
Jun 20095106
Jul 200912187
Aug 20098130
Sep 20091994
Oct 200920104
Nov 2009705
Dec 2009724
Jan 2010856
Feb 20101134
Mar 2010132
Apr 2010261
May 2010892
Jun 2010441
Jul 2010262
Aug 201011114
Sep 2010834
Oct 2010954
Nov 2010744
Dec 2010654
Jan 2011864
Feb 20114102
Mar 2011347
Apr 2011036
May 20118712
Jun 2011785
Jul 20115710
Aug 2011421
Sep 2011355
Oct 2011283
Nov 2011795
Dec 2011373
Jan 20121388
Feb 20125312
Mar 201217175
Apr 20121218
May 20124104
Jun 2012533
Jul 2012725
Aug 20127117
Sep 2012434
Oct 2012973
Nov 2012536
Dec 20121049
Jan 201318136
Feb 2013558
Mar 2013564
Apr 20135108
May 20131149
Jun 2013144
Jul 2013235
Aug 20133142
Sep 20131963
Oct 20131445
Nov 20134134
Dec 20139138
Jan 2014853
Feb 20142911
Mar 201414126
Apr 20141454
May 201421914
Jun 201452212
Jul 2014945
Aug 201432324
Sep 201441716
Oct 201471819
Nov 2014112212
Dec 2014299
Jan 20151081
Feb 2015557
Mar 20151094
Apr 2015451
May 20156121
Jun 20151264
Jul 20151777
Aug 201520181
Sep 2015660
Oct 2015240
Nov 2015363
Dec 2015453
Jan 20161027
Feb 20161894
Mar 2016719
Apr 2016051
May 20161113
Jun 2016685
Jul 201612113
Aug 2016981
Sep 20165129
Oct 20166105
Nov 20165151
Dec 20162194
Jan 20171225
Feb 20170124
Mar 20170248
Apr 20173209
May 20175135
Jun 20175144
Jul 201762110
Aug 201732113
Sep 201701710
Oct 20178156
Nov 20171195
Dec 20173143
Jan 2018491
Feb 20184125
Mar 20181195
Apr 20182186
May 20183223
Jun 20185366
Jul 20181145
Aug 20181256
Sep 20180264
Oct 20180184
Nov 20181134
Dec 20182430
Jan 20191300
Feb 2019611
Mar 20191221
Apr 2019320
May 20191500
Jun 20191302
Jul 2019800
Aug 20192071
Sep 20191021
Oct 20191100
Nov 20192300
Dec 20192200
Jan 20201410
Feb 20201100
Mar 20201300
Apr 2020210
May 2020500
Jun 20201113
Jul 2020700
Aug 2020511
Sep 2020710
Oct 2020410
Nov 2020810
Dec 20202110
Jan 20211020
Feb 2021812
Mar 20211010
Apr 2021610
May 2021821
Jun 2021410
Jul 20211210
Aug 2021410
Sep 2021820
Oct 20211010
Nov 2021821
Dec 20211760
Jan 20221000
Feb 2022430
Mar 2022720
Apr 2022810
May 2022710
Jun 20221110
Jul 2022810
Aug 20221221
Sep 20221110
Oct 2022710
Nov 20221100
Dec 2022510
Jan 2023910
Feb 2023410
Mar 2023810

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 64 (6)
Molecular Pharmacology
Vol. 64, Issue 6
1 Dec 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Heterogeneous Role of Caspase-8 in Fenretinide-Induced Apoptosis in Epithelial Ovarian Carcinoma Cell Lines
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Heterogeneous Role of Caspase-8 in Fenretinide-Induced Apoptosis in Epithelial Ovarian Carcinoma Cell Lines

Kimberly R. Kalli, Kathryn E. Devine, Myles C. Cabot, Christina R. Arnt, Michael P. Heldebrant, Phyllis A. Svingen, Charles Erlichman, Lynn C. Hartmann, Cheryl A. Conover and Scott H. Kaufmann
Molecular Pharmacology December 1, 2003, 64 (6) 1434-1443; DOI: https://doi.org/10.1124/mol.64.6.1434

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Heterogeneous Role of Caspase-8 in Fenretinide-Induced Apoptosis in Epithelial Ovarian Carcinoma Cell Lines

Kimberly R. Kalli, Kathryn E. Devine, Myles C. Cabot, Christina R. Arnt, Michael P. Heldebrant, Phyllis A. Svingen, Charles Erlichman, Lynn C. Hartmann, Cheryl A. Conover and Scott H. Kaufmann
Molecular Pharmacology December 1, 2003, 64 (6) 1434-1443; DOI: https://doi.org/10.1124/mol.64.6.1434
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics